Feed ISRG
IS

Intuitive Surgical

ISRG · NASDAQ

$369.15 +1.54% (+$5.59)
1M -5.43%
Market Cap $130.4B
P/E Ratio 41.55x
Div. Yield -
ROE 17.84%

Bulios Fair Price

$267.32

27.6% downside

Current Price

$369.15

Undervalued Fair Value Overvalued

According to Bulios Fair Price, ISRG is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Strong
7/9
Valuation
12 /100
Expensive
PEG 1.99x
P/E 41.55x
P/B 7.18x
Growth
99 /100
Growing
FCF growth 37.49%
EPS growth 29.19%
Book val. growth 17.31%
Profitability
100 /100
Strong
Op. margin 31.28%
Gross margin 66.68%
FCF margin 29.21%
Quality
79 /100
Excellent
ROA 15.04%
ROIC 15.11%
Asset turnover 0.53x
Debt
100 /100
Low
Net debt/EBITDA -0.61x
Debt/Equity 0.00x
Current ratio 4.96x
Stability
84 /100
Stable
EPS volatility 7.75%
Beta 1.47x
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about ISRG
Online

About the company

Intuitive Surgical, Inc. (ISRG) is an American company operating in the field of medical technologies. The company is known for its main product, the da Vinci Surgical System, which is a robotic surgical system designed to minimize invasive surgical procedures. The da Vinci Surgical System enables surgeons to perform complex operations with high precision and smaller incisions, resulting in reduced patient recovery time and minimized complications. Intuitive Surgical is a leader in the field of robotic-assisted surgery and has a wide range of applications for various surgical procedures. The company also provides expert support and training for surgeons to effectively use their technologies. Intuitive Surgical has a strong research and development team focused on continuous improvement and innovation of its products. Intuitive Surgical, Inc. (ISRG) shares are an attractive choice for investors who follow medical technologies and seek investment opportunities in a leading company in the field of robotic surgery.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

David J. Rosa

Employees

17,021

Headquarters

Sunnyvale

Upcoming events

20 OCT

Earnings

Upcoming earnings report

36d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.